The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
Shevach, E. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.003 · Cited by 549
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
Grossmann, M. E., Huang, H., & Tindall, D. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1687 · Cited by 548
Activation of Thymic Regeneration in Mice and Humans following Androgen Blockade
Sutherland, J. S., Goldberg, G. L., Hammett, M. V., Uldrich, A. P., Berzins, S. P., Heng, T. S., Blazar, B. R., Millar, J. L., Malin, M. A., Chidgey, A. P., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2741 · Cited by 486
Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing
Sfanos, K. S., Bruno, T. C., Maris, C. H., Xu, L., Thoburn, C. J., DeMarzo, A. M., Meeker, A. K., Isaacs, W. B., & Drake, C. G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5164 · Cited by 427
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
Miller, A. M., Lundberg, K., Özenci, V., Banham, A. H., Hellström, M., Egevad, L., & Pisa, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7398 · Cited by 421
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
Morgan, M. E., van Bilsen, J. H. M., Bakker, A. M., Heemskerk, B., Schilham, M. W., Hartgers, F. C., Elferink, B. G., van der Zanden, L., de Vries, R. R. P., Huizinga, T. W. J., et al. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.05.016 · Cited by 418
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer
Mercader, M., Bodner, B. K., Moser, M. T., Kwon, P. S., Park, E. S. Y., Manecke, R. G., Ellis, T. M., Wojcik, E. M., Yang, D., Flanigan, R. C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251140998 · Cited by 393
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
Drake, C. G., Doody, A. D. H., Mihalyo, M. A., Huang, C.-T., Kelleher, E., Ravi, S., Hipkiss, E. L., Flies, D. B., Kennedy, E. P., Long, M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.027 · Cited by 289
Shimura, S., Yang, G., Ebara, S., Wheeler, T. M., Frolov, A., & Thompson, T. C. (2000) · PubMed · Cited by 271
Vesalainen, S., Lipponen, P., Talja, M., & Syrjänen, K. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)e0159-2 · Cited by 254
Expression and Nuclear Localization of ErbB3 in Prostate Cancer
Koumakpayi, I. H., Diallo, J., Page, C. L., Lessard, L., Gleave, M. E., Bégin, L. R., Mes‐Masson, A., & Fred Saad, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2242 · Cited by 151
Self-citationFradet, V., Lessard, L., Bégin, L. R., Karakiewicz, P. I., Mes‐Masson, A., & Fred Saad, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0764 · Cited by 131
Self-citationAndrogen Deprivation Induces Phenotypic and Functional Changes in the Thymus of Adult Male Mice*
Olsen, N. J., WATSON, M. B., HENDERSON, G. S., & Kovacs, W. J. (1991) · Endocrinology · doi:10.1210/endo-129-5-2471 · Cited by 130
McArdle, P., Canna, K., McMillan, D. C., McNicol, A. M., Campbell, R., & Underwood, M. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601943 · Cited by 124
Kärjä, V. J., Aaltomaa, S. H., Lipponen, P., Isotalo, T., Talja, M. T., & Mokka, R. (2005) · PubMed · Cited by 124
NF‐κB nuclear localization and its prognostic significance in prostate cancer
Lessard, L., Mes‐Masson, A., Lamarre, L., Wall, L., Lattouf, J., & Fred Saad, C. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04104.x · Cited by 116
Self-citationIrani, J., Goujon, J., Ragni, E., Peyrat, L., Hubert, J., Saint, F., & Mottet, N. (1999) · Urology · doi:10.1016/s0090-4295(99)00152-1 · Cited by 107
Prostate inflammation and its potential impact on prostate cancer: A current review
Haverkamp, J. M., Charbonneau, B., & Ratliff, T. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21536 · Cited by 96
Page, C. L., Koumakpayi, I. H., Alam‐Fahmy, M., Mes‐Masson, A., & Fred Saad, C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603184 · Cited by 89
Self-citationTumor escape mechanisms in prostate cancer
Miller, A. M., & Pisa, P. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0110-x · Cited by 83
The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma
Richardsen, E. H., Uglehus, R. D., Due, J., Busch, C., & Busund, L.-T. R. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03058.x · Cited by 82
Ohlson, N., Wikström, P., Stattin, P. E., & Bergh, A. R. J. (2004) · The Prostate · doi:10.1002/pros.20139 · Cited by 75
Pathological changes in prostate lesions after androgen manipulation.
Montironi, R., & Schulman, C. C. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.1.5 · Cited by 58
Oefelein, M. G., Ricchiuti, V. S., Conrad, P. W., Goldman, H. B., Bodner, D. R., Resnick, M. I., & Seftel, A. D. (2002) · Urology · doi:10.1016/s0090-4295(02)01633-3 · Cited by 43
Diallo, J., Aldejmah, A., Filali-Mouhim, A., Péant, B., Fahmy, M. A., Koumakpayi, I. H., Sircar, K., Bégin, L. R., Mes‐Masson, A., & Fred Saad, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1224 · Cited by 36
Self-citationEarly effects of pharmacological androgen deprivation in human prostate cancer
Mercader, M., Sengupta, S., Bodner, B. K., Manecke, R. G., Cosar, E. F., Moser, M. T., Ballman, K. V., Wojcik, E. M., & Kwon, E. D. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.06538.x · Cited by 34
Fox, S. B., Launchbury, R., Bates, G. J., Cheng, H., Shaida, N., Malone, P. R., Harris, A. L., & Banham, A. H. (2007) · The Prostate · doi:10.1002/pros.20538 · Cited by 29
Diallo, J., Aldejmah, A., Filali-Mouhim, A., Fahmy, M. A., Koumakpayi, I. H., Sircar, K., Bégin, L. R., Mes‐Masson, A., & Fred Saad, C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07514.x · Cited by 26
Self-citationSári, Sari, Serel, Serel, Çandir, Ö., Öztürk, & Kosar (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00245.x · Cited by 23
Cited by
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Beer, T. M., Kwon, E. D., Drake, C. G., Fizazi, K., Logothetis, C., Gravis, G., Ganju, V., Polikoff, J., Saad, F., Humanski, P., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.1584 · Cited by 765
Self-citationGenetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Control of Metastasis by NK Cells
López-Soto, A., Gonzalez, S., Smyth, M. J., & Galluzzi, L. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.009 · Cited by 736
Clinical implications of PTEN loss in prostate cancer
Jamaspishvili, T., Berman, D. M., Ross, A. E., Scher, H. I., De Marzo, A. M., Squire, J. A., & Lotan, T. L. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.9 · Cited by 651
Metadata
- Authors
- Gannon, P. O., Poisson, A. O., Delvoye, N., Lapointe, R., Mes-Masson, A.-M., & Saad, F.
- Venue
- Journal of Immunological Methods
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 348
- Issue
- 1-2
- Pages
- 9-17
- ISSN
- 0022-1759 (ISSN-L)
- OpenAlex
- W2062135418
- Cited by
- 261
- References
- 32
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.